Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Inogen Inc. Stock

Price
Target price
€6.35

€6.35

2.480%
0.15
2.480%
€6.53
 
26.04.24 / Tradegate WKN: A1XB32 / Symbol: INGN / Name: Inogen / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Inogen Inc. in the next few years
Wizard

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Inogen Inc. is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Inogen

sharewise wants to provide you with the best news and tools for Inogen, so we directly link to the best financial data sources.

Financials

News

Broker

 

News

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2024 financial

BusinessWire_EN 
0 10.04.24
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced management will participate in the 23rd Annual

BusinessWire_EN 
0 25.03.24
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4): https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective March 4, 2024, the Compensation

BusinessWire_EN 
0 07.03.24
Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the

BusinessWire_EN 
0 27.02.24
Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report fourth quarter and full year

BusinessWire_EN 
0 30.01.24
Inogen Names Michael Bourque as New Chief Financial Officer: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen Names Michael Bourque as New Chief Financial Officer


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Michael Bourque as Chief

BusinessWire_EN 
0 24.01.24
Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO


Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of Directors has appointed Kevin

BusinessWire_EN 
0 13.11.23
Inogen to Present at Upcoming Investor Conferences in November 2023: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen to Present at Upcoming Investor Conferences in November 2023


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following

BusinessWire_EN 
0 09.11.23
Inogen Announces Third Quarter 2023 Financial Results: https://mms.businesswire.com/media/20220804005173/en/622619/5/Inogen_Logo_300_DPI.jpg
Inogen Announces Third Quarter 2023 Financial Results


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September

BusinessWire_EN 
0 07.11.23